GH1 and Prader-Willi syndrome: PWS is an indication for growth hormone therapy (GHT), as its clinical features, such as impaired growth, abnormal body composition, hypotonia, and low energy expenditure, closely resemble those seen in growth hormone deficiency (GHD) unrelated to PWS.